AHK-Cu: research, legal status and who sells it
This page is information, not medical advice. AHK-Cu is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- Ala-His-Lys copper complex, L-alanyl-L-histidyl-L-lysine-Cu2+
- Category
- Copper complex of the tripeptide Ala-His-Lys
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $0.297/mg to $1.60/mg, median $0.615/mg across 24 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains AHK-Cu [1]. |
| United Kingdom | No UK-licensed medicine containing AHK-Cu appears in the MHRA products database [2]. |
| European Union | No medicine containing AHK-Cu is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing AHK-Cu appears in Health Canada's Drug Product Database [5]. |
| Australia | AHK-Cu is not named in Australia's Poisons Standard, which lists copper compounds for human use in Schedule 4 except low-strength preparations [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7]. |
We haven't published a full overview of AHK-Cu yet. The legal status table and live prices on this page are current.
AHK-Cu prices: cheapest listings
The five lowest $/mg listings out of 38. See all AHK-Cu prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Iron Aminos | 40 | 100 mg × 10 | $297 | $0.297/mg | View | ||
| Bulk Peptide Wholesale | 45 | 100 mg × 10 | $300 | $0.300/mg | View | ||
| Modern Research Peptides | 10 | 100 mg × 10 | $327 | $0.327/mg | View | ||
| Modern Research Peptides | 10 | 100 mg | $33 | $0.330/mg | View | ||
| Premier Bio Labs | 72 | 100 mg | $34 | $0.340/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "ahk-cu". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research (2007). Accessed Oct 15, 2026